RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
70 hedge funds and large institutions have $426M invested in Revance Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
24% less call options, than puts
Call options by funds: $427K | Put options by funds: $560K
Holders
70
Holding in Top 10
2
Calls
$427K
Puts
$560K
Top Buyers
| 1 | +$13.4M | |
| 2 | +$10.4M | |
| 3 | +$4.15M | |
| 4 |
Bank of New York Mellon
New York
|
+$2.92M |
| 5 |
VAM
Visium Asset Management
New York
|
+$2.38M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$4.28M | |
| 3 | -$1.69M | |
| 4 |
ZDA
Zweig-DiMenna Associates
New York
|
-$1.41M |
| 5 |
Millennium Management
New York
|
-$1.38M |